Fact CheckerSign in

NCT06823843CompletedPhase 4

The Effect of Sublingual Nitroglycerin on Absolute Coronary Blood Flow

The Effect of Sublingual Nitroglycerin on Absolute Coronary Blood Flow: A Randomised, Placebo-controlled, Mechanistic Trial

Source: ClinicalTrials.gov · Last updated 28 Mar 2025

Brief summary (registry, in English)

The goal of this clinical trial is to investigate the effect of sublingual nitroglycerin on absolute coronary blood flow in adult patients undergoing coronary angiography. The main questions it aims to answer are: * Does sublingual nitroglycerin change absolute coronary blood flow compared to placebo? * What is the effect of sublingual nitroglycerin on important cardioavascular parameters such as coronary pressure and resistance? Researchers will compare the sublingual nitroglycerin group to the placebo group to see if nitroglycerin leads to significant changes in coronary blood flow and microvascular function. Participants will: * Receive either sublingual nitroglycerin or a placebo during coronary angiography. * Undergo coronary blood flow measurements before and after the intervention using standardized assessment techniques.

Status (registry)
Completed
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
40 (actual)
First submitted
4 Feb 2025
Start date
1 Jul 2024
Primary completion date
30 Sept 2024
Lead sponsor
VZW Cardiovascular Research Center Aalst
NCT number
NCT06823843

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 40
  • From 1 Jul 2024 to the primary completion date, 30 Sept 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of vasoactive medications within 24 hours of coronary angiography

Other illness

  • Clinical signs or symptoms of congestive heart failure
  • Severe valvular heart disease requiring either surgical or percutaneous intervention
  • History of coronary artery bypass grafting
  • Significant arrhythmia

Other

  • ≥1 severe stenosis (defined as a diameter stenosis \>70%)
  • Tortuous coronary anatomy in which wire manipulation could be complex

Who the study is looking for

  • Referred for invasive coronary angiography (ICA) for suspected coronary artery disease

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
OLV Cardiovascular Center Aalst
Coordinator of this site? Confirm its status
AalstBelgiumUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.